Merck and CLEARink Displays sign development agreement
Aim to commercialize video-capable, color-reflective displays
Merck announced that it has signed a comprehensive materials development agreement with CLEARink Displays, Inc., aiming to bring CLEARink’s innovative and patented reflective display technology to market by the end of 2017.
Merck is a world leader in developing materials and formulations for the LCD and OLED industries. It has also been developing reflective display materials for several years. Merck’s electro-optical inks are designed for electrophoretic displays and specifically support the CLEARink Displays’ TIR architecture. CLEARink displays offer unparalleled outdoor readability, full color and video representation, low power consumption and low cost, and are thus well-positioned to create a whole new class of display applications. The first CLEARink displays in kit form will be available in the first half of 2017, with commercial product release expected in early 2018. “CLEARink is a technology leader in reflective color displays for mobile devices. We are very excited to collaborate with the capable team at CLEARink because its technology allows for fast response and high brightness,” said Brian Daniels, Vice President and Head of the Advanced Technologies business unit at Merck. “This agreement is the culmination of four years of hard work and close cooperation between the two companies.”
Initially targeted applications in the mobile device space include smart watches and bands, mobile phones, portable e-Schoolbooks, electronic shelf labels and others. CLEARink has commenced reference design activities with a very select set of leaders in the space.
“We have been working with Merck since the very beginning to develop best-in-class materials for our displays. Today we are within striking distance of our goals to release a much needed product into the market,” said Frank Christiaens, CEO of CLEARink Displays. “In the past six months, interest in our technology from customers, investors and partners in the eco-system has been overwhelming.” CLEARink Displays will pursue a strategy of selling display modules made by its eco-system partners and will also license its technology for display companies to make their own products.
Merck announced several research grants and challenges during the company’s 350th anniversary year in addition to already existing initiatives. The new research grants and challenges are mainly directed to scientists working in institutes, universities or start-up companies around the world ... more
Merck held its 23rd Annual General Meeting. The company’s 350th anniversary was one of the overriding themes. Stefan Oschmann, CEO and Chairman of the Executive Board, reported to around 1,300 Merck shareholders on business developments and strategic moves in 2017 and presented an outlook f ... more
Merck announced changes in the leadership team of its Performance Materials business sector. Dorothea Wenzel will become the new Head of Controlling and Strategy. Hans-Joachim Neumann will take over the leadership of Integrated Supply Chain. In addition, the Group Function Environment, Heal ... more
Just Prove it. Spectroquant® ProveSpectroquant Prove 100 is the ideal VIS spectrophotometer for routine applications, such as wastewater analysis. We could tell you that Prove 100 is fast, easy-to-use and offers reliable results with direct insertion of cell tests and all this would be abso ... more
Just Prove It. Spectroquant® ProveSpectroquant Prove 300 is a robust UV/VIS spectrophotometer for sensitive measurements, such as drinking water and beverages analysis. Prove 300 allows UV/VIS analysis. It also detects automatically reagent tests for secure measurement of sensitive paramete ... more
Just Prove it. Spectroquant® ProveSpectroquant Prove 600 is a powerful UV/VIS spectrophotometer for complex analyses, such as process water testing. It offers all the benefits of the Prove 300 system and delivers in addition excellent resolution and sensitivity. Prove 600 is designed for hi ... more
Merck KGaA, Darmstadt, Germany, is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclero ... more